AAPL281.85-1.93 (-0.68%) ▼|ABBV255.27+1.92 (+0.76%) ▲|ABT92.83-1.29 (-1.37%) ▼|ACN125.04-3.94 (-3.05%) ▼|ADBE205.97+3.24 (+1.60%) ▲|AMAT697.48+70.64 (+11.27%) ▲|AMD536.72+15.14 (+2.90%) ▲|AMGN359.93+1.60 (+0.45%) ▲|AMT167.94-7.66 (-4.36%) ▼|AMZN240.09+7.40 (+3.18%) ▲|AVGO373.33+8.31 (+2.28%) ▲|AXP341.59+1.23 (+0.36%) ▲|BA215.39-1.86 (-0.86%) ▼|BAC58.12+0.24 (+0.41%) ▲|BKNG183.41+1.95 (+1.07%) ▲|BLK953.48-11.23 (-1.16%) ▼|BMY57.68+0.16 (+0.28%) ▲|BNY144.55+0.99 (+0.69%) ▲|BRK-B496.38-2.28 (-0.46%) ▼|C143.43+1.67 (+1.17%) ▲|CAT1,030.95+33.48 (+3.36%) ▲|CL91.54-0.53 (-0.58%) ▼|CMCSA24.60+1.43 (+6.17%) ▲|COF203.27-0.73 (-0.36%) ▼|COP104.98-0.99 (-0.93%) ▼|COST944.63-7.91 (-0.83%) ▼|CRM158.08-0.29 (-0.18%) ▼|CSCO117.87+4.10 (+3.60%) ▲|CVS103.62-0.72 (-0.69%) ▼|CVX169.70-1.36 (-0.80%) ▼|DE616.09+2.85 (+0.46%) ▲|DHR192.02-4.17 (-2.13%) ▼|DIS98.89+0.10 (+0.10%) ▲|DUK127.92-0.48 (-0.37%) ▼|EMR142.90-0.60 (-0.41%) ▼|FDX324.30+5.77 (+1.81%) ▲|GD349.37+2.66 (+0.77%) ▲|GE373.19+4.19 (+1.13%) ▲|GEV1,103.00+57.83 (+5.53%) ▲|GILD125.85-2.03 (-1.59%) ▼|GM78.28+0.18 (+0.23%) ▲|GOOG351.10+16.41 (+4.90%) ▲|GOOGL353.10+15.71 (+4.66%) ▲|GS1,025.85+6.24 (+0.61%) ▲|HD349.50+0.64 (+0.18%) ▲|HON236.93-6.49 (-2.66%) ▼|IBM276.12+4.49 (+1.65%) ▲|INTC130.75+2.43 (+1.89%) ▲|INTU267.01-0.72 (-0.27%) ▼|ISRG407.62+3.35 (+0.83%) ▲|JNJ256.32+1.66 (+0.65%) ▲|JPM331.28+2.23 (+0.68%) ▲|KO82.24-0.40 (-0.48%) ▼|LIN509.98-9.64 (-1.86%) ▼|LLY1,219.25+11.13 (+0.92%) ▲|LMT505.29-2.11 (-0.42%) ▼|LOW220.59-1.89 (-0.85%) ▼|LRCX410.91+31.82 (+8.39%) ▲|MA511.37+12.35 (+2.47%) ▲|MCD267.39-2.38 (-0.88%) ▼|MDLZ59.84-0.95 (-1.56%) ▼|MDT81.29+0.31 (+0.38%) ▲|META565.86+15.61 (+2.84%) ▲|MMM163.37-0.65 (-0.39%) ▼|MO73.31-0.48 (-0.65%) ▼|MRK128.43-0.23 (-0.18%) ▼|MS213.93+1.90 (+0.89%) ▲|MSFT369.26-3.71 (-0.99%) ▼|MU1,114.47-17.87 (-1.58%) ▼|NEE87.92-0.64 (-0.72%) ▼|NFLX74.32+0.51 (+0.69%) ▲|NKE41.47+0.72 (+1.75%) ▲|NOW100.20+1.86 (+1.89%) ▲|NVDA194.17+1.64 (+0.85%) ▲|ORCL148.58+0.05 (+0.03%) ▲|PEP137.89-3.50 (-2.48%) ▼|PFE24.25-0.04 (-0.16%) ▼|PG147.25-1.77 (-1.19%) ▼|PLTR116.62+3.69 (+3.26%) ▲|PM180.32-0.46 (-0.25%) ▼|QCOM191.17+1.78 (+0.94%) ▲|RTX188.08+0.09 (+0.05%) ▲|SBUX104.23-0.38 (-0.36%) ▼|SCHW90.61-0.06 (-0.07%) ▼|SO96.58-0.58 (-0.60%) ▼|SPG227.21+0.32 (+0.14%) ▲|T21.78-0.94 (-4.15%) ▼|TMO502.85-10.18 (-1.98%) ▼|TMUS175.40-7.28 (-3.99%) ▼|TSLA409.28+29.57 (+7.79%) ▲|TXN289.81+4.39 (+1.54%) ▲|UBER75.02-1.18 (-1.55%) ▼|UNH417.51-10.38 (-2.43%) ▼|UNP270.30+1.95 (+0.73%) ▲|UPS107.70-0.44 (-0.41%) ▼|USB61.31+0.40 (+0.66%) ▲|V341.90+5.67 (+1.69%) ▲|VZ43.85-2.69 (-5.78%) ▼|WFC84.09+0.23 (+0.27%) ▲|WMT114.36-1.33 (-1.15%) ▼|XOM136.74+0.20 (+0.15%) ▲|AAPL281.85-1.93 (-0.68%) ▼|ABBV255.27+1.92 (+0.76%) ▲|ABT92.83-1.29 (-1.37%) ▼|ACN125.04-3.94 (-3.05%) ▼|ADBE205.97+3.24 (+1.60%) ▲|AMAT697.48+70.64 (+11.27%) ▲|AMD536.72+15.14 (+2.90%) ▲|AMGN359.93+1.60 (+0.45%) ▲|AMT167.94-7.66 (-4.36%) ▼|AMZN240.09+7.40 (+3.18%) ▲|AVGO373.33+8.31 (+2.28%) ▲|AXP341.59+1.23 (+0.36%) ▲|BA215.39-1.86 (-0.86%) ▼|BAC58.12+0.24 (+0.41%) ▲|BKNG183.41+1.95 (+1.07%) ▲|BLK953.48-11.23 (-1.16%) ▼|BMY57.68+0.16 (+0.28%) ▲|BNY144.55+0.99 (+0.69%) ▲|BRK-B496.38-2.28 (-0.46%) ▼|C143.43+1.67 (+1.17%) ▲|CAT1,030.95+33.48 (+3.36%) ▲|CL91.54-0.53 (-0.58%) ▼|CMCSA24.60+1.43 (+6.17%) ▲|COF203.27-0.73 (-0.36%) ▼|COP104.98-0.99 (-0.93%) ▼|COST944.63-7.91 (-0.83%) ▼|CRM158.08-0.29 (-0.18%) ▼|CSCO117.87+4.10 (+3.60%) ▲|CVS103.62-0.72 (-0.69%) ▼|CVX169.70-1.36 (-0.80%) ▼|DE616.09+2.85 (+0.46%) ▲|DHR192.02-4.17 (-2.13%) ▼|DIS98.89+0.10 (+0.10%) ▲|DUK127.92-0.48 (-0.37%) ▼|EMR142.90-0.60 (-0.41%) ▼|FDX324.30+5.77 (+1.81%) ▲|GD349.37+2.66 (+0.77%) ▲|GE373.19+4.19 (+1.13%) ▲|GEV1,103.00+57.83 (+5.53%) ▲|GILD125.85-2.03 (-1.59%) ▼|GM78.28+0.18 (+0.23%) ▲|GOOG351.10+16.41 (+4.90%) ▲|GOOGL353.10+15.71 (+4.66%) ▲|GS1,025.85+6.24 (+0.61%) ▲|HD349.50+0.64 (+0.18%) ▲|HON236.93-6.49 (-2.66%) ▼|IBM276.12+4.49 (+1.65%) ▲|INTC130.75+2.43 (+1.89%) ▲|INTU267.01-0.72 (-0.27%) ▼|ISRG407.62+3.35 (+0.83%) ▲|JNJ256.32+1.66 (+0.65%) ▲|JPM331.28+2.23 (+0.68%) ▲|KO82.24-0.40 (-0.48%) ▼|LIN509.98-9.64 (-1.86%) ▼|LLY1,219.25+11.13 (+0.92%) ▲|LMT505.29-2.11 (-0.42%) ▼|LOW220.59-1.89 (-0.85%) ▼|LRCX410.91+31.82 (+8.39%) ▲|MA511.37+12.35 (+2.47%) ▲|MCD267.39-2.38 (-0.88%) ▼|MDLZ59.84-0.95 (-1.56%) ▼|MDT81.29+0.31 (+0.38%) ▲|META565.86+15.61 (+2.84%) ▲|MMM163.37-0.65 (-0.39%) ▼|MO73.31-0.48 (-0.65%) ▼|MRK128.43-0.23 (-0.18%) ▼|MS213.93+1.90 (+0.89%) ▲|MSFT369.26-3.71 (-0.99%) ▼|MU1,114.47-17.87 (-1.58%) ▼|NEE87.92-0.64 (-0.72%) ▼|NFLX74.32+0.51 (+0.69%) ▲|NKE41.47+0.72 (+1.75%) ▲|NOW100.20+1.86 (+1.89%) ▲|NVDA194.17+1.64 (+0.85%) ▲|ORCL148.58+0.05 (+0.03%) ▲|PEP137.89-3.50 (-2.48%) ▼|PFE24.25-0.04 (-0.16%) ▼|PG147.25-1.77 (-1.19%) ▼|PLTR116.62+3.69 (+3.26%) ▲|PM180.32-0.46 (-0.25%) ▼|QCOM191.17+1.78 (+0.94%) ▲|RTX188.08+0.09 (+0.05%) ▲|SBUX104.23-0.38 (-0.36%) ▼|SCHW90.61-0.06 (-0.07%) ▼|SO96.58-0.58 (-0.60%) ▼|SPG227.21+0.32 (+0.14%) ▲|T21.78-0.94 (-4.15%) ▼|TMO502.85-10.18 (-1.98%) ▼|TMUS175.40-7.28 (-3.99%) ▼|TSLA409.28+29.57 (+7.79%) ▲|TXN289.81+4.39 (+1.54%) ▲|UBER75.02-1.18 (-1.55%) ▼|UNH417.51-10.38 (-2.43%) ▼|UNP270.30+1.95 (+0.73%) ▲|UPS107.70-0.44 (-0.41%) ▼|USB61.31+0.40 (+0.66%) ▲|V341.90+5.67 (+1.69%) ▲|VZ43.85-2.69 (-5.78%) ▼|WFC84.09+0.23 (+0.27%) ▲|WMT114.36-1.33 (-1.15%) ▼|XOM136.74+0.20 (+0.15%) ▲|
30.5 C
New York
Monday, June 29, 2026

Tag: patients

newssourceFORcompanyinformationcontent1releasesmarket

Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs in oncology  and infectious diseases, and DiamiR Biosciences (“DiamiR”), a developer of proprietary innovative blood-based tests for brain health and other diseases with a CLIA licensed, CAP accredited clinical laboratory in New Haven, CT, today announced that they have entered into a definitive agreement for an all-stock merger transaction, in which DiamiR Biosciences will retain its name and become a wholly-owned subsidiary of Aptorum Group upon consummation of the merger.The combined company expects to remain listed on the Nasdaq Stock Market following the closing of the merger.

MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics’ EsoGuard® Esophageal DNA Test

Virtual public CAC meeting to be held September 4, 2025, at 2:00 p.m. ET NEW YORK, July 16, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid"...

Leading Drug Delivery Conference PODD Announces its 15th Annual Agenda

The Conference Forum announces the 15th annual PODD Drug Delivery Conference's 2025 agenda and featured sessions. NEW YORK, July 16, 2025 /PRNewswire/ -- Today, PODD: Partnership...

Fortrea Announces Date for Second Quarter 2025 Financial Results and Conference Call

DURHAM, N.C., July 16, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second quarter 2025 financial results before the market opens on Wednesday, August 6, 2025. Fortrea will host a conference call at 8:00 am ET that day to review its financial results and conduct a question-and-answer session.

Safi Biotherapeutics and Functional Fluidics Initiate Collaboration to Validate Health and Quality of Manufactured RBCs

Collaboration to support Safi IND data package for use of mRBCs in sickle cell disease chronic transfusions CAMBRIDGE, Mass. and DETROIT, July 16, 2025 /PRNewswire/...

WuXi Biologics Granted Highest Negligible-Risk ESG Rating from Morningstar Sustainalytics

Best ESG rating tier of negligible-risk with a top 1% global ranking scoreIndustry and Regional ESG Top-Rated Company for five consecutive yearsLeader in Green...

Piccolo Medical, Inc. Receives FDA Clearance for 2nd Generation SmartPICC® technology

SAN FRANCISCO, July 16, 2025 /PRNewswire/ -- Piccolo Medical, Inc. (Piccolo), a leading innovator in vascular access technology, today announced it has received 510(k) clearance...

TFS HealthScience Strengthens Global Ophthalmology Unit with Strategic Hires and Integrated Delivery Model

LUND, Sweden, July 16, 2025 /PRNewswire/ -- TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is expanding its ophthalmology business unit with...

TFS HealthScience Strengthens Global Ophthalmology Unit with Strategic Hires and Integrated Delivery Model

LUND, Sweden, July 16, 2025 /PRNewswire/ -- TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is expanding its ophthalmology business unit with...

Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration

Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration

Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection

TOKYO, July 15, 2025 /PRNewswire/ -- Fujitsu Limited and Acer Medical Inc., a provider of AI-powered medical imaging and preventative medicine, today announced a...

Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection

TOKYO, July 16, 2025 /PRNewswire/ -- Fujitsu Limited and Acer Medical Inc., a provider of AI-powered medical imaging and preventative medicine, today announced a...

Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors

TAIPEI and SAN DIEGO, July 15, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for...

Medley Expands Operations in the Philippines to Accelerate Global Growth

MANILA, Philippines, July 16, 2025 /PRNewswire/ -- Medley (TSE: 4480), a leading Japan-based healthcare technology group, has announced the relocation and expansion of its operational...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatients

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers